) Q1’20 Consolidated Financial Results 12 May 2020 Q1’20 Management Discussion & Analysis Page 2/6 Financial Performance Summary for Q1’20 OSP reported total revenue of THB 6,906 million, an increase of
, an increase of 18.52 million baht from the same period last year, representing 70.99 percent The total revenue was divided into revenue from real estate development business of 43.76 million baht
in order to increase sales, in the meantime focus on control system and reduce expenses to conform actual incomes which decreased. Performance Analysis Unit : MB For the quarterly Change For the six
6.72 million baht or 3.07% due to the increase of unit transfer and promotion expenses in Q2/2020 - Administrative expenses in Q2/2020 amounted 196.54 million baht compared to Q2/2019 which was 185.86
280.62 16.5 * excluding fuel cost Increase (Decrease) % Quarter 1 The operating result for the 1st quarter of 2020 showed the profit (attributable to owners of the Company) of THB 1,360.82 million
Owners of the parent 27.96 8.19% 41.21 34.30% (13.25) (32.15%) Jan – Mar 63 Jan – Mar 62 Increase/(Decrease) DOD BIOTECH PUBLIC COMPANY LIMITED เลขท ี111 หมู่ท ี2 ตําบลท่าจีน อําเภอเมืองสมุทรสาคร จังหวดั
electricity were THB 176 million in the second quarter of 2020, which increased by THB 90 million or 105% from the same period last year. The increase was mainly because the Company recognized RH’s and AVA’s
occur from several projects and backlogs of IGE and subsidiaries. The contracts of the projects have been postponed and made the revenue recognition is not on schedule. 2. Sales and Services increase from
slowdown of investment environment throughout the country. Cost of goods sold and services decreased in portion of decreasing revenue but expenses were increase at the same level as last year and interest
profit (loss) The company recorded net loss of 19.05 million Baht in the third quarter of 2019, increase of 17.20 million Baht compared with net profit of 1.85 million Baht in the same quarter last year